Clinical trials: Irritant Contact Dermatitis, open to volunteers
Irritant Contact Dermatitis
Glycyrrhetinic Acid and Acute Irritant Dermatitis
Irritant dermatitis is one of the most common inflammatory skin disorders, caused by exposure to external substances that induce inflammation and immune activation.
- Trial name
- NCT07286487
- Testing
- SLS induced irritation, No Treatment, Low Dose Glycyrrhetinic Acid Formulation
- Where
- Croatia
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- University of Split, School of Medicine
Diaper Dermatitis
Breast Milk Versus Barrier Creams for Diaper Dermatitis in Children Aged 0-24 Months
Diaper dermatitis is a common inflammatory skin condition among children aged 0-24 months. Although commercial barrier creams are widely used, maternal breast milk has been suggested as a safe, accessible, and low-cost…
- Trial name
- NURSE-DD (NCT07633808)
- Testing
- Topical Maternal Breast Milk, Commercial Barrier Cream
- Where
- Palestinian Territories
- Volunteers
- 160 people
- Sponsor
- University of Malaya
Fecal Incontinence, Urinary Incontinence
Improving the Care of Incontinence-Associated Dermatitis (IAD) Using a Beta-Glucan Cream as a Hydrating and Soothing Agent
The goal of this clinical trial is to determine whether adding a β-glucan moisturizing cream to routine skin care can enhance skin healing, accelerate visible recovery, reduce discomfort, and improve both patient and clinician…
- Conditions
- Fecal Incontinence, Urinary Incontinence, Diaper Rash, Irritant Contact Dermatitis Caused by Faeces
- Trial name
- NCT07524439
- Testing
- Soothing Beta Cream (Dr. Mom), Standard of Care
- Where
- Canada
- Volunteers
- 60 people
- Sponsor
- University of Alberta
Diaper Dermatitis
Probiotics for Diaper Dermatitis
The goal of this randomized controlled clinical trial is to determine the effect of the probiotic OMNiBiOTiC® Panda in treating diaper dermatitis in children under the age of two years.
- Trial name
- ProDiaper II (NCT06755307)
- Testing
- OMNiBiOTiC® Panda
- Where
- Slovenia
- Volunteers
- 42 people
- Sponsor
- University Maribor
Irritant Dermatitis, Stoma Site Dermatitis
Effectiveness of 3M Cavilon Advanced Skin Protectant in the Treatment of Moisture-associated Skin Damage in Hospitals
Objectives: The aim of this study is to evaluate the effectiveness of 3M™ Cavilon™ Advanced Skin Protectant in the treatment of partial-thickness wounds caused by moisture (MASD) compared to usual wound care treatment.
- Conditions
- Irritant Dermatitis, Stoma Site Dermatitis, Wound of Skin
- Trial name
- ISR-CASP-MASD (NCT06178289)
- Testing
- 3M Cavilon Advanced Skin Protectant, Standard hospital wound treatment protocol
- Where
- 3 sites in Belgium
- Volunteers
- 36 people
- Sponsor
- University Ghent
Diaper Dermatitis
Neonatal Intensive Care Unit (NICU) Diaper Dermatitis: Prevention and Treatment With Airtime
The purpose of this study is to investigate the use of 3-5 minutes air therapy for the prevention and treatment of diaper dermatitis in infants 30 weeks and older receiving care in the neonatal intensive care unit (NICU).
- Trial name
- NCT06958003
- Testing
- Air Therapy
- Where
- United States
- Volunteers
- 320 people
- Sponsor
- TriHealth Inc.
Skin Barrier Disruption and Recovery
Helichrysum Italicum Extract in Irritant Contact Dermatitis
The goal of this clinical trial is to evaluate the efficacy and safety of a topical cream containing Immortelle (Helichrysum italicum) extract in promoting skin barrier recovery and reducing signs of irritant contact dermatitis…
- Trial name
- NCT07676253
- Testing
- Helichrysum italicum Extract Cream
- Where
- Croatia
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- University of Split, School of Medicine